GL1X · GenesisL1 explorer

MolNFT v1 · #30772 · protein

Crystal structure of catalytic domain of clostridium botulinum neurotoxin serotype F

2A97 · Botulinum neurotoxin type F: “Crystal structure of catalytic domain of clostridium botulinum neurotoxin serotype F”. X-ray diffraction, 2 ligands (CD, ZN), 8 pockets (best druggability 0.68). MolNFT v1 #30772 on GenesisL1: 3D…

PDB
2A97
Type
protein
Length
784 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type F
EC
3.4.24.69
UniProt
P30996
Ligands
CD, ZN
Pockets
8 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBotulinum neurotoxin type F (EC 3.4.24.69)protein39235% helix, 18% strandP30996

Ligands and binding sites

  • CD · Cadmium ion · metal · 7 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13130.680.8333ZN
23670.640.7935empty
32830.640.8031CD
4660.470.8314empty
51130.410.7619empty

Interfaces

1 interface between chains.

  • A–B · 882 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 2A97 · Crystal structure of catalytic domain of Clostridium botulinum neurotoxin serotype F · the same entry in another collection · chain A against A, TM-score 1.00
  • P30996 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type F (P30996) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.